Tirzepatide generic price explained: no FDA-approved generic exists yet, so here's what Zepbound and Mounjaro cost with insurance, GoodRx, or cash.
There is no FDA-approved generic tirzepatide for sale in the United States as of late 2025. That means the tirzepatide generic price people are searching for is really the lowest legal cash price on the brand-name versions: Zepbound for weight loss and Mounjaro for type 2 diabetes. Today those prices run from about $349 to $499 a month through the manufacturer's self-pay pharmacy, and roughly $1,000 or more at a retail counter without insurance.
Is There a Generic Tirzepatide Yet?
No. Tirzepatide is a patented molecule, and Eli Lilly holds the US patents that block generic copies. The FDA has approved only two brand-name products containing it: Mounjaro, approved in 2022, and Zepbound, approved in 2023.
Generic competition in the US is not expected until the mid-2030s at the earliest. Patent terms vary by country, so lower-cost versions may reach markets such as India, Canada, and Brazil well before they appear in the United States.
As of 2025, no FDA-approved generic version of tirzepatide exists in the United States.
Be skeptical of any website advertising “generic tirzepatide” today. Those products are usually research chemicals, overseas imports, or compounded drugs — none of which are FDA-approved generic equivalents.
What Tirzepatide Costs Right Now
List prices change often, but the table below shows the typical monthly ranges US patients see for a 28-day supply.
| Purchasing option | Typical monthly cost | Notes |
|---|---|---|
| Manufacturer self-pay vial, 2.5 mg | About $349 | Cash only, no insurance accepted |
| Manufacturer self-pay vial, 5 mg and up | About $499 | Higher doses may cost the same |
| Retail pen without insurance | About $1,050–$1,100 | List price before any discount |
| GoodRx or discount card | Roughly $1,000–$1,100 | Savings on brand drugs are limited |
| Commercial insurance with prior authorization | $0–$150 copay | Depends on the plan and formulary |
| Compounded tirzepatide | Was $200–$500 | Not FDA-approved; large-scale compounding ended in 2025 |
Insurance coverage is the single biggest factor in what you pay. Plans that cover Zepbound or Mounjaro for type 2 diabetes often cover them at a standard copay, while weight-loss coverage is far less consistent.
How to Find the Best Price
Shopping for the tirzepatide best price means comparing three or four channels before you fill anything. Spending 20 minutes on the phone can save several hundred dollars a month.
- Check your insurance formulary and ask whether prior authorization is required.
- Compare your pharmacy copay against the manufacturer's self-pay vial program.
- Ask about a manufacturer savings card if you have commercial insurance.
- Ask your clinician whether a higher-strength vial fits your dosing plan, since the price per milligram drops.
- Look into clinical trials, which usually provide the drug at no cost to participants.
Medicare Part D generally does not cover tirzepatide for weight loss, though some plans cover it for type 2 diabetes. Medicaid coverage varies by state.
Does GoodRx Lower the Tirzepatide Cost?
GoodRx and similar discount cards can help, but the savings on brand-name tirzepatide are usually small. Because Zepbound and Mounjaro list above $1,000, pharmacy discount cards typically shave off only a modest amount.
- GoodRx coupons often land near $1,000–$1,100 a month.
- GoodRx Gold members sometimes see slightly lower rates.
- Discount cards cannot be combined with most manufacturer savings cards.
- They are most useful when you pay cash and your insurance covers nothing.
So a search for tirzepatide cost goodrx usually leads to the same conclusion: a small discount on a very large list price. Discount cards are not insurance, and they do not change the fact that no generic exists.
Compounded Tirzepatide: What Changed
During the shortage, compounding pharmacies sold tirzepatide for roughly $200 to $500 a month. The FDA resolved the shortage in late 2024, and large-scale compounding of copies was phased out in early 2025.
Compounded tirzepatide is not FDA-approved and has not been reviewed for safety, quality, and effectiveness the way brand products are. Strength and purity can also vary between pharmacies. A state-licensed pharmacy may still prepare it in narrow cases, such as a documented reaction to an ingredient in the brand product, but the broad mail-order market has largely closed.
Other Options People Compare
Because tirzepatide is expensive, many people research related peptides and next-generation weight-loss drugs at the same time. Researchers exploring fat loss often look into aod 9604 with tirzepatide, and early trial data have made cagrilintide vs tirzepatide a frequent comparison. Vitamin injections are another common add-on, which is why interest in lipo c with b12 with tirzepatide has grown alongside GLP-1 use.
None of those combinations are part of tirzepatide's FDA-approved labeling, and stacking products raises the risk of side effects and dosing errors. Talk with a clinician before adding anything to a tirzepatide regimen.
When Will Generic Tirzepatide Arrive?
Most industry analysts expect the first US generic tirzepatide to reach pharmacies in the mid-2030s, not before. A few factors could shift that timeline in either direction.
- Patent litigation: Lilly has sued to defend its patents, and court outcomes can extend exclusivity by years.
- Regulatory path: a generic maker must file an abbreviated application and prove bioequivalence.
- Market demand: with millions of users, several manufacturers are likely to compete quickly once the door opens.
- Global timing: launches in India, Canada, and Brazil are expected well before US entry.
When generics do launch, prices typically fall by 50% or more within the first year or two, based on how other large drug markets have behaved. Until then, the brand price is the only legal price in the United States.
Safety Notes Before You Buy
Tirzepatide can cause nausea, vomiting, diarrhea, constipation, and injection-site reactions. It also carries warnings for pancreatitis, gallbladder disease, and thyroid C-cell tumors observed in animal studies, and it should not be used by anyone with a personal or family history of medullary thyroid cancer or MEN2.
Buy only from a licensed US pharmacy with a prescription from a licensed clinician. Importing tirzepatide from overseas or ordering from an unverified website raises real risks of counterfeit product and incorrect dosing. Tirzepatide is a prescription medicine, and a healthcare professional should guide your dose and monitor your progress.
Frequently Asked Questions
Will there ever be a generic version of tirzepatide?
Yes, but not soon. Eli Lilly's US patents on tirzepatide block generic copies, and most analysts expect the first US generic to reach pharmacies in the mid-2030s. Generic versions may launch earlier in countries such as India, Canada, and Brazil, where patent terms differ.
What is the cheapest way to get tirzepatide right now?
The lowest listed cash price in the US is the manufacturer's self-pay vial program, which runs about $349 to $499 a month depending on dose. If your insurance covers Zepbound or Mounjaro with a prior authorization, your copay may be lower than that, often between $0 and $150.
Does GoodRx cover tirzepatide?
GoodRx is a discount card, not insurance, and it offers only modest savings on brand-name tirzepatide. Coupons typically land near $1,000 to $1,100 a month, and they usually cannot be combined with a manufacturer savings card. GoodRx is most useful when you are paying cash with no insurance coverage at all.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.